Showing results (181-190 of 210) with videos related to
Sort By:
Pageof 21
International Journal of Clinical Oncology|June 8, 2014
Opioid needs of terminally ill patients with gynecologic malignanciesFumi Utsumi, Hiroaki Kajiyama, Jun Sakata, et al.Cancer Immunology, Immunotherapy : CII|November 13, 2012
Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapyDaisuke Nobuoka, Toshiaki Yoshikawa, Mari Takahashi, et al.The Plant Journal : for Cell and Molecular Biology|June 12, 2018
Downregulation of p-COUMAROYL ESTER 3-HYDROXYLASE in rice leads to altered cell wall structures and improves biomass saccharificationYuri Takeda, Yuki Tobimatsu, Steven D Karlen, et al.Gynecologic Oncology|May 21, 2021
A randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab versus dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent, or persistent cervical carcinoma (JCOG1311): Primary analysisMitsuya Ishikawa, Taro Shibata, Takashi Iwata, et al.Gynecologic Oncology|August 29, 2020
Investigation of clinicopathological features of vulvar cancer in 1068 patients: A Japanese Gynecologic Oncology Group (JGOG) nationwide survey studyShin Nishio, Kenta Murotani, Sari Nakao, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 26, 2025
Efficient expansion of tumor-infiltrating lymphocytes from gynecologic cancerTetsuya Matsukawa, Tsunenori Ouchida, Taeko Hayakawa, et al.International Journal of Clinical Oncology|December 3, 2024
Prospective changes in financial toxicity and health-related quality of life in patients with gynecologic cancerKazunori Honda, Yusuke Kajimoto, Shiro Suzuki, et al.International Journal of Oncology|June 21, 2011
Identification of an HLA-A*0201-restricted cytotoxic T lymphocyte epitope from the lung carcinoma antigen, LengsinMunehide Nakatsugawa, Kazutaka Horie, Toshiaki Yoshikawa, et al.Gynecologic Oncology|June 10, 2008
Is there any possibility of fertility-sparing surgery in patients with clear-cell carcinoma of the ovary?Hiroaki Kajiyama, Kiyosumi Shibata, Shiro Suzuki, et al.Oncogene|January 9, 2021
Expression of the chrXq27.3 miRNA cluster in recurrent ovarian clear cell carcinoma and its impact on cisplatin resistanceKosuke Yoshida, Akira Yokoi, Mai Sugiyama, et al.Pageof 21